Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
499 Leser
Artikel bewerten:
(2)

Breit Biniazan: Jury Awards $360 Million in Landmark Sexual Abuse Verdict

Landmark jury verdict against Cumberland Children's Hospital and its former medical director. Jury awards three plaintiffs $360 million for sexual abuse and neglect.

RICHMOND, VA / ACCESSWIRE / October 4, 2024 / On Friday, September 27, a Richmond Circuit Court jury delivered a groundbreaking $360 million verdict in a civil trial against Cumberland Hospital and its former medical director. After roughly seven hours of deliberations, the jurors returned a verdict of $20 million in compensatory damages, $60 million in treble damages for violation of Virginia's Consumer Protection Act, and $40 million in punitive damages per plaintiff.

Breit Biniazan Legal Team

Breit Biniazan Legal Team
Image of attorneys providing comment to the media after the landmark $360 million jury verdict was announced.

The jury found the former medical director sexually abused each plaintiff under the guise of femoral pulse exams. In closing arguments, attorney Kevin Biniazan described the environment at Cumberland as a "village" of abuse, urging the jury to consider the long-term impact of the defendant's actions on the victims' lives.

"One [victim] is a problem, two is a pattern, three is pervasive, and four is a pandemic," Biniazan stated, emphasizing the need for justice and support for the survivors. He highlighted that a favorable verdict would send a powerful message to victims, affirming their worth and restoring their trust in the system.

Cumberland Hospital is one of several hundred facilities operated as a subsidiary of Universal Health Service, Inc. and through the management of UHS of Delaware, Inc. This verdict comes on the heels of a United States Senate Committee on Finance report and hearing addressing concerns with Youth Residential Treatment Facilities owned by UHS including Cumberland Hospital.

While the defense team attempted to defend the legitimacy of the defendant's medical examinations which habitually violated patients, the jurors ultimately determined that there was malicious intent behind his actions and negligence on the part of Cumberland Hospital for not protecting the children.

This landmark verdict highlights the urgent need for transparency and accountability in youth serving organizations, as the plaintiffs seek to reclaim their lives and send a clear message against abuse in all forms.

Breit Biniazan represents more than 40 additional plaintiffs involving claims against Cumberland Hospital, its parent company UHS, Inc., and the former medical director seeking in excess of $930 million.

About Breit Biniazan

Breit Biniazan is a trial-focused law firm made up of trial lawyers who are passionate and dedicated to finding justice for clients who have been harmed through no fault of their own. Breit Biniazan has achieved some of the largest personal injury, wrongful death, and medical malpractice settlements and verdicts in Virginia and Washington DC.

With offices throughout Virginia and Phoenix, Arizona, Breit Biniazan represents catastrophically injured clients in trucking, products liability, sexual abuse, and medical malpractice disputes. Breit Biniazan's success in handling the most significant injury cases has also led to a successful mass tort and class action practice throughout the country.

Contact Information

Courtney Sweasy
Marketing Director
courtney@bbtrial.com
804-516-5830

SOURCE: Breit Biniazan

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.